Catalyst Event
Tempus AI Inc (TEM) · Other
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
3/25/2026, 12:00:00 AM
Announced a strategic collaboration with Daiichi Sankyo on 2026-03-25 to use Tempus' AI models to accelerate the clinical development of an antibody drug conjugate (ADC) program in oncology.
Korean Translation
2026년 3월 25일 다이이찌산쿄와 전략적 협력 관계를 발표함. Tempus의 AI 모델을 사용하여 종양학 분야의 항체-약물 접합체(ADC) 프로그램의 임상 개발을 가속화할 예정임.
Related Recent Events
Natera Inc (NTRA) · Earnings Release
Natera is expected to report its Q1 2026 earnings on May 7, 2026, with analysts forecasting an EPS of approximately -$0.55. Market impact is estimated at ≥1% as earnings dates are routine; scheduled.
5/7/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
Tempus AI is expected to announce its Q1 2026 earnings results on 2026-05-05. This routine announcement is estimated to have a ~1% price impact based on historical trends expected.
5/5/2026, 12:00:00 AM